Epidural Anesthetic Does Not Slow Labor Progress
By HospiMedica International staff writers Posted on 26 Oct 2017 |
Maintaining epidural infusion has no effect on the duration of the second stage of labor when compared with a placebo infusion, according to a new study.
Researchers at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) and Nanjing Medical University (China) conducted a double-blind, randomized, placebo-controlled trial involving 400 nulliparous women with singleton pregnancies who requested epidural analgesia. All women received patient-controlled epidural analgesia for the first stage of labor using 0.08% ropivacaine with 0.4 micrograms/mL sufentanil. At the onset of the second stage of labor, the women were randomized to receive a blinded infusion of the same solution or placebo saline infusion.
The primary outcome was the duration of the second stage of labor. The results revealed that the duration of the second stage of labor was similar between groups, at 52 minutes. Spontaneous vaginal delivery rate was also similar, at 96.5% for epidural infusion compared to 99% for saline. Pain scores were also similar between groups at each measurement during the second stage, as were incidence of episiotomy, the position of the fetus at birth, Apgar scores, umbilical artery pH, or any other measure of fetal wellbeing. The study was published on October 6, 2017, in Obstetrics & Gynecology.
“We found that exchanging the epidural anesthetic with a saline placebo made no difference in the duration of the second stage of labor. Not even the pain scores were statistically different between groups,” said senior author Philip Hess, MD, director of obstetric anesthesia at BIDMC. “Ethically, if epidural medications result in a negative effect on the second stage of labor, one could argue that a mild increase in maternal pain could be balanced by a successful vaginal delivery. We didn't see any negative effects, but epidural analgesia in the second stage of labor remains controversial and merits follow up studies.”
Epidural analgesia, which is achieved by a mixture of anesthetics and narcotics delivered by a catheter placed near the spine, is considered the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have long been thought to slow the second stage of labor--starting when the cervix is completely dilated and ending when the baby is delivered. Because a longer duration of this stage of labor is associated with adverse outcomes, obstetricians routinely reduce or discontinue epidural pain management in an effort to expedite this main stage of labor.
Related Links:
Beth Israel Deaconess Medical Center
Nanjing Medical University
Researchers at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) and Nanjing Medical University (China) conducted a double-blind, randomized, placebo-controlled trial involving 400 nulliparous women with singleton pregnancies who requested epidural analgesia. All women received patient-controlled epidural analgesia for the first stage of labor using 0.08% ropivacaine with 0.4 micrograms/mL sufentanil. At the onset of the second stage of labor, the women were randomized to receive a blinded infusion of the same solution or placebo saline infusion.
The primary outcome was the duration of the second stage of labor. The results revealed that the duration of the second stage of labor was similar between groups, at 52 minutes. Spontaneous vaginal delivery rate was also similar, at 96.5% for epidural infusion compared to 99% for saline. Pain scores were also similar between groups at each measurement during the second stage, as were incidence of episiotomy, the position of the fetus at birth, Apgar scores, umbilical artery pH, or any other measure of fetal wellbeing. The study was published on October 6, 2017, in Obstetrics & Gynecology.
“We found that exchanging the epidural anesthetic with a saline placebo made no difference in the duration of the second stage of labor. Not even the pain scores were statistically different between groups,” said senior author Philip Hess, MD, director of obstetric anesthesia at BIDMC. “Ethically, if epidural medications result in a negative effect on the second stage of labor, one could argue that a mild increase in maternal pain could be balanced by a successful vaginal delivery. We didn't see any negative effects, but epidural analgesia in the second stage of labor remains controversial and merits follow up studies.”
Epidural analgesia, which is achieved by a mixture of anesthetics and narcotics delivered by a catheter placed near the spine, is considered the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have long been thought to slow the second stage of labor--starting when the cervix is completely dilated and ending when the baby is delivered. Because a longer duration of this stage of labor is associated with adverse outcomes, obstetricians routinely reduce or discontinue epidural pain management in an effort to expedite this main stage of labor.
Related Links:
Beth Israel Deaconess Medical Center
Nanjing Medical University
Latest Patient Care News
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
- World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear